These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2827196)

  • 21. Assessing opioid regulation of adenylyl cyclase activity in intact cells.
    Thakker DR; Ozsoy HZ; Standifer KM
    Methods Mol Med; 2003; 84():29-37. PubMed ID: 12703314
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of several parameters of immune status, opioid and interferon systems in athletes].
    Surkina ID; Gotovtseva EP; Shestakova SV; Shchurin MR; Zozulia AA
    Biull Eksp Biol Med; 1990 Jan; 109(1):51-3. PubMed ID: 1692247
    [No Abstract]   [Full Text] [Related]  

  • 23. Modulatory role of lysophosphatidic acid on opioid receptor binding.
    Apaydin S; Oktem HA
    Neurobiology (Bp); 1998; 6(4):421-7. PubMed ID: 10220777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. Part 7: syntheses and opioid receptor properties of cyclic variants of cyclazocine.
    Wentland MP; Lu Q; Ganorkar R; Zhang SZ; Jo S; Cohen DJ; Bidlack JM
    Bioorg Med Chem Lett; 2009 Jan; 19(2):365-8. PubMed ID: 19091564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A kinetic model of the interaction of stable GTP analogs with a system of opioid receptors].
    Skliankina OA; Kurochkin IN; Keldysh PL; Zaĭtsev SV; Varfolomeev SD
    Biokhimiia; 1988 Feb; 53(2):205-13. PubMed ID: 2835995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent developments in bioassay using selective ligands and selective in vitro preparations.
    Kosterlitz HW; Corbett AD; Gillan MG; McKnight AT; Paterson SJ; Robson LE
    NIDA Res Monogr; 1986; 70():223-35. PubMed ID: 3020423
    [No Abstract]   [Full Text] [Related]  

  • 28. Binding properties of the pure opioid antagonist [3H](N-propyl)-noroxymorphone in rat brain membranes.
    Tóth G; Benyhe S; Hosztafi S; Borsodi A
    Neurobiology (Bp); 1993; 1(4):327-35. PubMed ID: 8069290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of morphine dependence and abstinence on opioid receptors in the cerebral cortex and spinal cord of the rat.
    Antkiewicz-Michaluk L; Michaluk J; Marona-Lewicka D; Vetulani J
    Pol J Pharmacol Pharm; 1988; 40(1):11-6. PubMed ID: 2853335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and opioid activity of side-chain-to-side-chain cyclic dynorphin A-(1-11) amide analogues cyclized between positions 2 and 5. 1. Substitutions in position 3.
    Vig BS; Murray TF; Aldrich JV
    J Med Chem; 2004 Jan; 47(2):446-55. PubMed ID: 14711314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Partial purification of endogenous inhibitors of (+)-[3H] SKF 10047 binding with sigma-opioid receptors of the liver].
    Nagornaia LV; Samovilova NN; Korobov NV; Vinogradov VA
    Biull Eksp Biol Med; 1988 Sep; 106(9):314-7. PubMed ID: 2844323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic structure-activity studies of peptide and nonpeptide flexible opioids: an interdisciplinary approach.
    Loew GH; Toll L; Uyeno E; Cheng A; Judd A; Lawson J; Keys C; Amsterdam P; Polgar W
    NIDA Res Monogr; 1986; 69():231-65. PubMed ID: 3020415
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple opiate receptors for multiple opioid peptides.
    Miller RJ
    Med Biol; 1982 Feb; 60(1):1-6. PubMed ID: 6121959
    [No Abstract]   [Full Text] [Related]  

  • 35. beta-Endorphin: radioreceptor binding assay. Relative potency of synthetic analogs with various chain lengths.
    Ferrara P; Li CH
    Int J Pept Protein Res; 1980 Jul; 16(1):66-9. PubMed ID: 6254895
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodological aspects on drug receptor binding analysis.
    Wahlström A
    Acta Pharmacol Toxicol (Copenh); 1978; 43 Suppl 2():74-8. PubMed ID: 213940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The three-dimensional structure of pharmacology].
    Goldstein A
    Sheng Li Ke Xue Jin Zhan; 1982 Jul; 13(3):284-7. PubMed ID: 6294826
    [No Abstract]   [Full Text] [Related]  

  • 38. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
    Aubert I; Guigoni C; Li Q; Dovero S; Bioulac BH; Gross CE; Crossman AR; Bloch B; Bezard E
    Biol Psychiatry; 2007 Apr; 61(7):836-44. PubMed ID: 16950226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct measurements of in situ interactions of rat brain opioid receptors with the guanine nucleotide-binding protein Go.
    Georgoussi Z; Carr C; Milligan G
    Mol Pharmacol; 1993 Jul; 44(1):62-9. PubMed ID: 8393523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Present status of research on narcotic receptors (author's transl)].
    Han JS
    Sheng Li Ke Xue Jin Zhan; 1981 Jan; 12(1):95-6. PubMed ID: 6274010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.